SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-18-013580
Filing Date
2018-09-21
Accepted
2018-09-21 16:05:31
Documents
12
Period of Report
2018-09-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 78688
2 ex2-1.htm EX-2.1 857112
3 ex10-1.htm EX-10.1 321878
4 ex10-2.htm EX-10.2 15567
5 ex10-3.htm EX-10.3 95429
6 ex99-1.htm EX-99.1 88404
7 ex99-2.htm EX-99.2 89653
8 ex99-3.htm EX-99.3 17352
9 ex99-4.htm EX-99.4 3244
10 ex99-4_001.jpg GRAPHIC 128834
11 ex99-4_002.jpg GRAPHIC 408206
12 ex99-4_003.jpg GRAPHIC 247405
  Complete submission text file 0001493152-18-013580.txt   2649581
Mailing Address 201 ROUTE 17 NORTH 2ND FLOOR RUTHERFORD NJ 07070
Business Address 201 ROUTE 17 NORTH 2ND FLOOR RUTHERFORD NJ 07070 201.528.9200
CANCER GENETICS, INC (Filer) CIK: 0001349929 (see all company filings)

IRS No.: 043462475 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35817 | Film No.: 181081674
SIC: 8071 Services-Medical Laboratories
Assistant Director 9